Hana Biosciences to trade on AMEX beginning Thursday

New York, Sept. 21 - Hana Biosciences, Inc. said its stock will begin trading on the American Stock Exchange on Thursday under the symbol "HBX."

Currently the shares trade as "HNAB" on the over-the-counter bulletin board.

The shift follows approval from the American Stock Exchange for the listing.

"Achieving our AMEX listing is another step forward in building shareholder value through our progress in developing and commercializing innovative treatments to improve cancer care," said Russell Skibsted, vice president and chief financial officer of Hana Biosciences, in a news release.

"We believe that current and future shareholders will benefit from the enhanced profile this listing gives our stock and from the greater liquidity we expect by trading on the AMEX."

Hana Biosciences is a South San Francisco, Calif., biopharmaceutical company focusing on treatments for cancer.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.